- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) President and Chief Technology Officer Cathy Fleischer, Ph.D. will present at the Third Annual Axiom Capital Management/Livingston Nanotechnology Conference in New York City at 2:40 p.m. Eastern (or EST), Friday, Dec. 7, 2007. The conference will be held at the Marriott Financial Center.
Fleischer said, "This conference is an opportunity for us to present the groundbreaking work that NaturalNano is doing both in the lab and with our joint development partners. We are also looking forward to showcasing the multiple advantages our proprietary, turn key additive, Pleximer™, brings to the marketplace in enabling manufacturers to create stronger, lighter and less expensive materials."
NaturalNano (www.naturalnano.com) also said it will discuss its recent nanomaterial licensing deal with the Naval Research Laboratory (NRL), and will give an update on its overall efforts toward product commercialization.
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer™ polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. For more information, visit http://www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
For more information, please click here
Lambert, Edwards & Associates
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016
IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016
Cutting-edge nanotechnologies are breaking into industries November 18th, 2016